News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Project team
We’ve been awarded a one million euro grant by the Ministry of Science to study brain tumor biomarkers with Fundación Rioja Salud and the University of the Balearic Islands
The Spanish government has announced the public grants corresponding to the State Program for…
Partners - Laminar Pharma
Logo de Oryzon
ORYZON to present further positive efficacy data from iadademstat ALICE Phase IIa trial at the 62nd Congress of the American Society of Hematology
Will also present at Jefferies 2020 Virtual London Healthcare Conference. CEO to participate…
Partners - Oryzon Genomics
ORYZON receives approval to start PORTICO Phase IIb trial with vafidemstat in Borderline Personality Disorder
ORYZON receives approval to start PORTICO Phase IIb trial with vafidemstat in Borderline Personality Disorder
Clinical Trial Application approved by Spanish Drug Agency
Oryzon announces appointment of Dr. Torsten Hoffmann as Global R&D Director and retirement of Dr. Tamara Maes
Oryzon announces appointment of Dr. Torsten Hoffmann as Global R&D Director and retirement of Dr. Tamara Maes
At Roche, Dr. Hoffmann was Head of Discovery Chemistry and Head of the Roche Postdoc Fellowship…
Marta Princep, co-founder & managing partner, and Albert Zamora, co-Founder & chairman of the Board (Photo: BHV Partners).
BHV Partners settles in the Barcelona Science Park and closes a 500,000 euros investment round
In just over a year of history, the company has established itself as a leading driver in the…
Partners - Parc Científic de Barcelona
Oryzon Reports Results for Quarter Ended September 30
Oryzon Reports Results for Quarter Ended September 30
Oryzon Genomics reported financial results for the third quarter of 2020 and provided an update on…
Partners - Oryzon Genomics
SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer
SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer
New investors include 4BIO Capital, UPMC Enterprises, Jeito Capital and Ysios Capital
Partners - Ysios Capital Partners
Oryzon Genomics SA
ORYZON holds its 4th annual Solidarity Day
The OSD is an annual initiative whereby the company's employees devote part of their working hours…
Partners - Oryzon Genomics
Asphalion joins Barcelona Health Hub to boost technological and digital innovation in the healthcare sector
Asphalion joins Barcelona Health Hub to boost technological and digital innovation in the healthcare sector
“New technologies are a key element of digital transformation in the healthcare sector", …
Partners - Asphalion